Pheon Therapeutics announces $120m Series B financing to fund development of its differentiated ADC pipeline

Pheon Therapeutics California

Financing led by TCGX, including new investment from BVF Partners, Lightspeed Venture Partners (Lightspeed) and Perceptive AdvisorsThree first-in-class ADC assets funded through clinical proof of conceptView original content:https://www.prnewswire.co.uk/news-releases/pheon-therapeutics-announces-120m-series-b-financing-to-fund-development-of-its-differentiated-adc-pipeline-302150537.html